Evidence map›Paper›PMID 27200341›Full record

ReviewFrontiers in chemistry2016

Base-Modified Nucleosides: Etheno Derivatives.

Zofia Jahnz-Wechmann, Grzegorz R Framski, Piotr A Januszczyk, Jerzy Boryski

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in chemistry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 33 citations in OpenAlex.

  1. Luminescence of NLuminescence : the journal of biological and chemical luminescence · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Modified mRNA as a Treatment for Myocardial Infarction.International journal of molecular sciences · 2023
    Review
  9. Article
  10. Article
  11. Double-headed nucleosides: Synthesis and applications.Beilstein journal of organic chemistry · 2021
    Review
  12. Review
  13. Article
  14. Article
  15. Metal-free synthesis of 1,RSC advances · 2019
    Article
  16. Article
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Zofia Jahnz-WechmannInstitute of Bioorganic Chemistry, Polish Academy of Sciences Poznan, Poland.
Grzegorz R FramskiInstitute of Bioorganic Chemistry, Polish Academy of Sciences Poznan, Poland.
Piotr A JanuszczykInstitute of Bioorganic Chemistry, Polish Academy of Sciences Poznan, Poland.
Jerzy BoryskiInstitute of Bioorganic Chemistry, Polish Academy of Sciences Poznan, Poland.
Institute of Bioorganic Chemistry, Polish Academy of Sciences · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This review presents synthesis and chemistry of nucleoside analogs, possessing an additional fused, heterocyclic ring of the "etheno" type, such as 1,N(6)-ethenoadenosine, 1,N(4)-ethenocytidine, 1,N(2)-ethenoguanosine, and other related derivatives. Formation of ethenonucleosides, in the presence of α-halocarbonyl reagents and their mechanism, stability, and degradation, reactions of substitution and transglycosylation, as well as their application in the nucleoside synthesis, have been described. Some of the discussed compounds may be applied as chemotherapeutic agents in antiviral and anticancer treatment, acting as pro-nucleosides of already known, biologically active nucleoside analogs.

Indexed as

antiviral activityethenonucleosidesfused heterocyclesnucleoside analogstricyclic acyclovirwyosine

Identifiers

PMID27200341
PMCPMC4848297
OpenAlexW2342792733

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.